-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

631.P1.27 631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, apoptosis, antibodies, Biological, Diseases, Therapies, CML, Mechanisms, Technology and Procedures, epigenetics, Study Population, Clinically relevant, hematopoiesis, Myeloid Malignancies, flow cytometry, TKI, NGS, RNA sequencing, signal transduction
Saturday, December 9, 2017: 5:30 PM-7:30 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center)

Amy Hughes, PhD1,2,3, Jade Clarson1,2*, Deborah L White, PhD, FRCPath4,5,6, David Yeung, PhD, BSc, FRACP, FRCPA, MBBS1,2,3, Timothy P. Hughes, MD, MBBS, FRACP, FRCPA1,2,3 and Agnes S. M. Yong, MD, PhD1,2,3

1Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, Australia
2Department of Haematology, SA Pathology, Adelaide, Australia
3School of Medicine, University of Adelaide, Adelaide, Australia
4Australasian Leukaemia and Lymphoma Group, Melbourne, Australia
5Cancer Theme, SAHMRI, Adelaide, SA, Australia
6School of Biological Sciences. Faculty of Sciences, University of Adelaide, Adelaide, Australia

Tetsuzo Tauchi, MD1*, Seiichi Okabe, MD, PhD2*, Seiichiro Katagiri, MD2*, Yuko Tanaka, MD, PhD2* and Kazuma Ohyashiki, MD, PhD2

1Tokyo Medical University, Tokyo, Japan
2Department of Hematology, Tokyo Medical University, Tokyo, Japan

Jun Toda, MD1*, Michiko Ichii, MD, PhD1*, Hirohiko Shibayama, MD, PhD1, Hideaki Saito, MD1*, Yuichi Kitai2*, Ryuta Muromoto2*, Jun-ichi Kashiwakura2*, Kodai Saitoh2*, Tadashi Matsuda2*, Kenji Oritani, MD, phD3* and Yuzuru Kanakura, MD, PhD1

1Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan
2Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan
3Department of Hematology, Graduate School of Medical Science, International University of Health and Welfare, Narita, Japan

Puneet Agarwal1*, Hui Li, BS2*, Andrew J Paterson, PhD2*, Jianbo He, MD2*, Takashi Nagasawa, MD, PhD3* and Ravi Bhatia, MD2

1Division of Hematology/Oncology, University of Alabama at Birmingham, Jacksonville, AL
2Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
3Department of Immunobiology and Hematology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan

Constance Regina Baer, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD and Torsten Haferlach, MD

MLL Munich Leukemia Laboratory, Munich, Germany

Wenjing Tao1*, Po Yee Mak1*, Michael Andreeff, MD, PhD2 and Bing Z Carter, PhD1

1Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Chetasi Talati, MD1, Leidy Isenalumhe, MD2,3, Andrew Kuykendall, MD4, Bijal D. Shah, MD5, Julio C. Chavez, MD2, Mohammad Omar Hussaini, MD6*, Javier Pinilla Ibarz, MD, PhD2 and Kendra L. Sweet, MD6

1University of South Florida/H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
2H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
3University of South Florida, Tampa, FL
4University of South Florida/H. Lee Moffitt Cancer Center, Tampa, FL
5Malignant Hematology, Moffit Cancer Center, Tampa, FL
6Moffitt Cancer Center, Tampa, FL

Manuela Mancini, PhD1*, Sara De Santis1*, Cecilia Monaldi1*, Fausto Castagnetti, MD, PhD2, Luana Bavaro1*, Margherita Martelli3*, Gabriele Gugliotta, MD, PhD1, Gianantonio Rosti, MD4,5,6,7*, Elena Tenti, PhD8*, Maria Alessandr Santucci, MD9*, Michele Cavo, MD10*, Giovanni Martinelli, MD11 and Simona Soverini, PhD12

1Department of Experimental Diagnostic and Specialty Medicine - DIMES Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna, Italy
2Department of Experimental Diagnostic and Specialty Medicine - DIMES Institute of Hematology "L. e A. Seràgnoli", Bologna University School of Medicine, Bologna, Italy
3Department of Experimental, Diagnostic and Specialty Medicine - DIMES, Institute of Hematology "L. and A. Seràgnoli", University of Bologna, Bologna, Italy
4Department of Experimental, Diagnostic and Specialty Medicine - DIMES, Institute of Hematology "L. and A. Seràgnoli", S.Orsola-Malpighi University Hospital, Bologna, Italy
5DIMES - University of Bologna, Bologna, Italy
6Institute of Hematology " L. & A. Seràgnoli",, St. Orsola University Hospital, Bologna, Italy
7Bologna University School of Medicine, Bologna, Italy
8Hematology/Oncology "Seragnoli", University of Bologna, Bologna, Italy
9Department of Experimental Diagnostic and Specialty Medicine - DIMES Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna, ITA
10Department of Physics and Astronomy, University of Bologna, Bologna, Italy
11Institute of Hematology 'Seragnoli', Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna,, Bologna, Italy
12Hematology/Oncology "L. e A. Seragnoli", University of Bologna, Bologna, ITA

*signifies non-member of ASH